Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,074.04
(
-0.49%
)
US TECH 100
25,808.80
(
-0.24%
)
Dow Jones
49,208.72
(
-0.48%
)
Brent Oil
94.31
(
4.00%
)
Bitcoin
75,570.73
(
-0.42%
)
News Focus
News Focus
Post# of 257432
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jessellivermore post# 97415

Monday, 08/02/2010 9:55:15 AM

Monday, August 02, 2010 9:55:15 AM

Post# of 257432
AGN is up 6% in early trading based on solid 2Q10 results. In spite of FDA approval today of a Botox competitor for cervical dystonia (#msg-52866968), AGN’s share price is within striking distance of its all-time high of $70.40 reached in early 2008.

Perhaps you’ve been unduly bearish on this company.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today